Ozempic, Wegovy, and Mounjaro have been linked to gastroparesis and bowel obstruction, and Alexander Shunnarah Trial Attorneys represents GLP-1 weight loss drug victims across Alabama
Originally developed for type 2 diabetes, semaglutide is now FDA-approved for weight management with options like Wegovy
Many studies have shown a U- or J-shaped relationship between BMI and mortality, where lower and higher BMI are associated with increased mortality risk compared to normal weight BMI levels (defined as a BMI between 18.5 to 25 kg/m)
It is important to note that GLP-1 receptor agonists are not indicated for type 1 diabetes
PlexusDx offers both compounded semaglutide injection (at $189/mo month-to-month, or from $149/mo on the 6-month plan) and oral semaglutide (at $289/mo month-to-month, or from $249/mo on the 6-month plan), allowing patients to choose based on lifestyle preference and how long they want medication effects to persist between doses
While Mounjaro offers a new approach to diabetes and obesity management, its cost could be a barrier, according to doctors